Mullennix Stephen 4
4 · UroGen Pharma Ltd. · Filed Apr 28, 2020
Insider Transaction Report
Form 4
Mullennix Stephen
Chief Operating Officer
Transactions
- Exercise/Conversion
Ordinary Shares
2020-04-26+417→ 10,229 total - Exercise/Conversion
Restricted Stock Units (RSUs)
2020-04-26−417→ 2,917 total→ Ordinary Shares (417 underlying) - Sale
Ordinary Shares
2020-04-27$24.35/sh−145$3,531→ 10,084 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
- [F2]Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.
- [F3]The reporting person was granted 5,000 Restricted Stock Units ("RSUs") on January 26, 2019. 33.33% of the RSUs vested on January 26, 2020 and 12.5% of the remaining RSUs will vest in eight equal quarterly installments thereafter.